SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
Acetylon Pharmaceuticals Initiates New Phase 1b Clinical Trial of Rocilinostat (ACY-1215) in Combination with Celgene Corporation's Revlimid® (Lenalidomide) and Dexamethasone for Patients with Multiple Myeloma